"Antipsychotics are at best marginally useful for treating patients with Alzheimer's who have mainly agitation, aggression,
or psychosis," Schneider told Psychiatric News. "Some studies show some beneficial effects, but these come with a price that involves an association with death, stroke,
risk for metabolic syndrome, and worsening cognition. The magnitude of this effect [on cognition] is of the same order of
magnitude as the therapeutic effect of Aricept."